Lipid nanoparticles: ready-to-use optimized formulations

Lipid nanoparticles: ready-to-use optimized formulations
Product Description

Adalid builds LNPs from libraries of ionizable lipids (flexible/constrained), helper lipids/sterols, and click-ready polymer-lipid stabilizers for ligand attachment. Our semi automated, high-throughput assembly platform delivers data-driven structure–performance maps, rapidly optimizing compositions for specific payloads, routes, and targets. Adalid offers ready-to-use LNP formulations for several usage scenarios, e.g. CAR-T therapies, vaccines, protein replacement. Adalid's technology is backed by extensive intellectual property rights. 

Read more Show less

Adalid Sciences

  • Country/Region:
    Czech Republic
  • Founded:
    2024
  • On CPHI since:
    2026
  • Employees:
    25 - 49
Company types
Start-up
Primary activities
Biopharmaceutical
Chemical Development
Contract Research Organisation
Laboratory, Analytical, Biotechnology Equipment
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Genomic medicine; vaccine development
More specifications Fewer specifications

Adalid Sciences

  • Country/Region:
    Czech Republic
  • Founded:
    2024
  • On CPHI since:
    2026
  • Employees:
    25 - 49
Company types
Start-up
Primary activities
Biopharmaceutical
Chemical Development
Contract Research Organisation
Laboratory, Analytical, Biotechnology Equipment
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Adalid Sciences (3)

  • Lipid nanoparticles for nucleic acids delivery - ionizable lipids

    Product Lipid nanoparticles for nucleic acids delivery - ionizable lipids

    Our ionizable-lipid libraries cover flexible and also conformationally constrained structures across conventional and new topologies, giving us precise control over LNP design for particular payloads and indications. Adalid's technology is backed by extensive intellectual property right...
  • Lipid nanoparticles for nucleic acids delivery - outer shell stabilizers

    Product Lipid nanoparticles for nucleic acids delivery - outer shell stabilizers

    Our libraries of lipid-polymer conjugates span diverse proprietary LNP stabilizers that tune particle properties and enable modular attachment of targeting ligands (e.g., antibodies and alternatives). Adalid's technology is backed by extensive intellectual property.
  • Optimization of lipid nanoparticles (LNPs) for nucleic acid delivery

    Product Optimization of lipid nanoparticles (LNPs) for nucleic acid delivery

    Adalid builds LNPs from libraries of ionizable lipids (flexible/constrained), helper lipids/sterols, and click-ready polymer-lipid stabilizers for ligand attachment. Our semi-automated, high-throughput assembly platform delivers data-driven structure-performance maps...